Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-04

AUTHORS

Michael S. Wolfe, Weiming Xia, Beth L. Ostaszewski, Thekla S. Diehl, W. Taylor Kimberly, Dennis J. Selkoe

ABSTRACT

Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease. The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intramembranous proteolysis by the elusive γ-secretase(s)1. The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the production of the highly amyloidogenic Aβ42 isoform2. Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity3, indicating that presenilin-1 mediates most of this proteolytic event. Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ production and increases the amounts of the carboxy-terminal fragments of β-amyloid precursor protein that are the substrates of γ-secretase. We observed these effects in three different cell lines as well as in cell-free microsomes. Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop. In a functional presenilin-1 variant (carrying a deletion in exon 9) that is associated with familial Alzheimer's disease and which does not require this cleavage4, the Asp 385 → Ala mutation still inhibited γ-secretase activity. Our results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique diaspartyl cofactor for γ-secretase or is itself γ-secretase, an autoactivated intramembranous aspartyl protease. More... »

PAGES

513-517

Journal

TITLE

Nature

ISSUE

6727

VOLUME

398

Related Patents

  • Γ-Secretase Substrates And Methods Of Use
  • Bispecific Antibody Fragments For Neurological Disease Proteins And Methods Of Use
  • Therapeutic Agents For Alzheimer's Disease And Cancer
  • Extracellular Markers Whereby Notch Signal Transduction Can Be Detected; These Peptides (N Beta ) Are Released From Cells In Proportion To Notch Signal Depending On Presenilin; By Detecting These Peptides, Notch Signal Transduction, Cell Differentiation, Apoptosis, Alzheimer's Disease Can Be Detected
  • Heterocyclic Methyl Sulfone Derivative
  • Treatment Of Amyloidoses Using Myelin Basic Protein And Fragments Thereof
  • Enzymatic Protein For Use In The Diagnosis, Treatment And Prevention Of Alzheimer's Disease And Nervous System Disorders
  • Amyloid Precursor Protein (App) Based Ã#-Secretase Inhibitor Peptides, And Methods Of Use
  • Gamma Three Protease
  • Treatment For Alzheimer's Disease And Related Conditions
  • Β-Amyloid Protein Production/Secretion Inhibitor
  • Method For Diagnosing Alzheimer's Disease Using Serum Glycoprotein As Biomarker
  • Inhibitors Of Memapsin 2 And Use Thereof
  • Methods For Identifying Compounds That Modulate Stabilization Of Secretase-Associated Proteins
  • Helical Peptidomimetics With Enhanced Activity
  • Therapeutic Agents For Alzheimer's Disease And Cancer
  • Coumarin-Based Compounds
  • Gamma-Secretase Stabilizing Compound Screening Assay
  • Modulating The Enzymatic Production Of A Beta - Amyloid Peptide (A Beta ) From A Beta -Amyloid Precursor Protein (App) Or Fragment, By Contacting App Or Fragment With A Bace2 Polypeptide Or An Agonist Or Antagonist
  • Fused, Tricyclic Sulfonamide Inhibitors Of Gamma Secretase
  • Transgenic Pig Model For A Hereditary Neurodegenerative Autosomal Dominant Disease
  • N-Substituted Benzene Sulfonamides
  • Regulation Of Gsk-3Α Activity For The Treatment Or Prevention Of Alzheimer's Disease
  • Catalytically Active Recombinant Memapsin And Methods Of Use Thereof
  • N-Substituted Benzene Sulfonamides
  • Methods And Compositions For Gamma-Secretase Assay
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/19077

    DOI

    http://dx.doi.org/10.1038/19077

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1004359799

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10206644


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Neurosciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Alzheimer Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amyloid Precursor Protein Secretases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amyloid beta-Peptides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amyloid beta-Protein Precursor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aspartic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aspartic Acid Endopeptidases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "CHO Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COS Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Membrane", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell-Free System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Coenzymes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cricetinae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Electrochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Endopeptidases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Exons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Microsomes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutagenesis, Site-Directed", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Peptide Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Presenilin-1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Folding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transfection", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Pharmaceutical Sciences, University of Tennessee, 38163, Memphis, Tennessee, USA", 
              "id": "http://www.grid.ac/institutes/grid.267301.1", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
                "Department of Pharmaceutical Sciences, University of Tennessee, 38163, Memphis, Tennessee, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wolfe", 
            "givenName": "Michael S.", 
            "id": "sg:person.0624424615.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624424615.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xia", 
            "givenName": "Weiming", 
            "id": "sg:person.0735711351.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735711351.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ostaszewski", 
            "givenName": "Beth L.", 
            "id": "sg:person.01021240275.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021240275.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Diehl", 
            "givenName": "Thekla S.", 
            "id": "sg:person.01277266475.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277266475.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kimberly", 
            "givenName": "W. Taylor", 
            "id": "sg:person.0611613126.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611613126.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Selkoe", 
            "givenName": "Dennis J.", 
            "id": "sg:person.0606140311.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606140311.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/359322a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026401285", 
              "https://doi.org/10.1038/359322a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm0296-224", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001947768", 
              "https://doi.org/10.1038/nm0296-224"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/30756", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041325757", 
              "https://doi.org/10.1038/30756"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/34910", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053079917", 
              "https://doi.org/10.1038/34910"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/19083", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048748829", 
              "https://doi.org/10.1038/19083"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/387288a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005421437", 
              "https://doi.org/10.1038/387288a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1999-04", 
        "datePublishedReg": "1999-04-01", 
        "description": "Accumulation of the amyloid-\u03b2 protein (A\u03b2) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease. The final step in the generation of A\u03b2 from the \u03b2-amyloid precursor protein is an apparently intramembranous proteolysis by the elusive \u03b3-secretase(s)1. The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters \u03b3-secretase activity to increase the production of the highly amyloidogenic A\u03b242 isoform2. Moreover, deletion of presenilin-1 in mice greatly reduces \u03b3-secretase activity3, indicating that presenilin-1 mediates most of this proteolytic event. Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp\u2009257 (in TM6) and Asp\u2009385 (in TM7), substantially reduces A\u03b2 production and increases the amounts of the carboxy-terminal fragments of \u03b2-amyloid precursor protein that are the substrates of \u03b3-secretase. We observed these effects in three different cell lines as well as in cell-free microsomes. Either of the Asp \u2192 Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 \u2192 TM7 cytoplasmic loop. In a functional presenilin-1 variant (carrying a deletion in exon 9) that is associated with familial Alzheimer's disease and which does not require this cleavage4, the Asp\u2009385 \u2192 Ala mutation still inhibited \u03b3-secretase activity. Our results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and \u03b3-secretase activity, and suggest that presenilin 1 is either a unique diaspartyl cofactor for \u03b3-secretase or is itself \u03b3-secretase, an autoactivated intramembranous aspartyl protease.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/19077", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6727", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "398"
          }
        ], 
        "keywords": [
          "\u03b2-amyloid precursor protein", 
          "\u03b3-secretase activity", 
          "presenilin 1", 
          "familial Alzheimer's disease", 
          "Alzheimer's disease", 
          "\u03b3-secretase", 
          "presenilin 1 variants", 
          "precursor protein", 
          "generation of A\u03b2", 
          "cerebral cortex", 
          "common cause", 
          "carboxy-terminal fragment", 
          "disease", 
          "presenilin endoproteolysis", 
          "intramembranous proteolysis", 
          "cell lines", 
          "different cell lines", 
          "transmembrane aspartates", 
          "mutations", 
          "aspartyl protease", 
          "proteolytic events", 
          "pathogenesis", 
          "invariant events", 
          "activity", 
          "cytoplasmic loop", 
          "cortex", 
          "mice", 
          "A\u03b2", 
          "endoproteolysis", 
          "Ala mutation", 
          "microsomes", 
          "protein", 
          "cause", 
          "events", 
          "isoform2", 
          "aspartate", 
          "activity3", 
          "deletion", 
          "Asp", 
          "protease", 
          "variants", 
          "genes", 
          "accumulation", 
          "proteolysis", 
          "effect", 
          "production", 
          "cofactor", 
          "lines", 
          "final step", 
          "fragments", 
          "TM6", 
          "results", 
          "amount", 
          "residues", 
          "aspartate residue", 
          "loop", 
          "generation", 
          "step", 
          "substrate"
        ], 
        "name": "Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and \u03b3-secretase activity", 
        "pagination": "513-517", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1004359799"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/19077"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10206644"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/19077", 
          "https://app.dimensions.ai/details/publication/pub.1004359799"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:22", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_324.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/19077"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/19077'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/19077'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/19077'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/19077'


     

    This table displays all metadata directly associated to this object as RDF triples.

    287 TRIPLES      21 PREDICATES      117 URIs      103 LITERALS      33 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/19077 schema:about N03430eed234445fea60ed46a31d7329b
    2 N06638c2b19a34ca5bf491557ad4311dd
    3 N0cc9a639685441598be599c5ccd508c9
    4 N0fe8598898564c749e1b8dd91c7404cd
    5 N11a1bb0eb94a494b8019b586e7de139a
    6 N11cd40ee8b7a4f0e97a3be3e8d62c78a
    7 N209d423470494b238e77022dd6676a34
    8 N2312c6ea39b844dbbdfe23b57d1bbf1c
    9 N2ae83eca851e4d7b89adfff987157edd
    10 N3226b200aa5c4c3f835787ee3a9d3296
    11 N3afecbc855f140e5be4d28fd950d011c
    12 N46dc1305600f42c0be2717142b2edb29
    13 N608d96d11f1242b088d4e0db58e98673
    14 N62bd1190bfe8438b972d66fe509e61f8
    15 N7a1e2e6228814c2d8be0325021f9d07c
    16 N848c0304e86d4e0eb1daf2a0fd2fae5b
    17 N8846016a62164997936b90dfe6e66b38
    18 N8bb3b1761f3c4a25aade99e53235d770
    19 N8c1aa9db905f4df199744a9c2cdea308
    20 N8f22642d182a4e32b15db3cc2c5dba26
    21 Nad7763ff249c4146b37aa43a41942b74
    22 Ne29f23f6a14f47f3a2d052e4d10809d2
    23 Nf1870a37bbfc44079a2506e3a2d42ac5
    24 Nf99bc7c51f0148dba686533d6e25166b
    25 Nfb30e7a2d44f4ae39e383e52a0eed443
    26 Nff4cf8cf8728438fbb208e857d873286
    27 anzsrc-for:11
    28 anzsrc-for:1109
    29 schema:author Nbc435153d7784364ab82058588635b60
    30 schema:citation sg:pub.10.1038/19083
    31 sg:pub.10.1038/30756
    32 sg:pub.10.1038/34910
    33 sg:pub.10.1038/359322a0
    34 sg:pub.10.1038/387288a0
    35 sg:pub.10.1038/nm0296-224
    36 schema:datePublished 1999-04
    37 schema:datePublishedReg 1999-04-01
    38 schema:description Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease. The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intramembranous proteolysis by the elusive γ-secretase(s)1. The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the production of the highly amyloidogenic Aβ42 isoform2. Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity3, indicating that presenilin-1 mediates most of this proteolytic event. Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ production and increases the amounts of the carboxy-terminal fragments of β-amyloid precursor protein that are the substrates of γ-secretase. We observed these effects in three different cell lines as well as in cell-free microsomes. Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop. In a functional presenilin-1 variant (carrying a deletion in exon 9) that is associated with familial Alzheimer's disease and which does not require this cleavage4, the Asp 385 → Ala mutation still inhibited γ-secretase activity. Our results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique diaspartyl cofactor for γ-secretase or is itself γ-secretase, an autoactivated intramembranous aspartyl protease.
    39 schema:genre article
    40 schema:isAccessibleForFree false
    41 schema:isPartOf Nc7a2e015729646c990aca2bce1977e65
    42 Ne12e990492484e36b471feb15c008916
    43 sg:journal.1018957
    44 schema:keywords Ala mutation
    45 Alzheimer's disease
    46 Asp
    47
    48 TM6
    49 accumulation
    50 activity
    51 activity3
    52 amount
    53 aspartate
    54 aspartate residue
    55 aspartyl protease
    56 carboxy-terminal fragment
    57 cause
    58 cell lines
    59 cerebral cortex
    60 cofactor
    61 common cause
    62 cortex
    63 cytoplasmic loop
    64 deletion
    65 different cell lines
    66 disease
    67 effect
    68 endoproteolysis
    69 events
    70 familial Alzheimer's disease
    71 final step
    72 fragments
    73 generation
    74 generation of Aβ
    75 genes
    76 intramembranous proteolysis
    77 invariant events
    78 isoform2
    79 lines
    80 loop
    81 mice
    82 microsomes
    83 mutations
    84 pathogenesis
    85 precursor protein
    86 presenilin 1
    87 presenilin 1 variants
    88 presenilin endoproteolysis
    89 production
    90 protease
    91 protein
    92 proteolysis
    93 proteolytic events
    94 residues
    95 results
    96 step
    97 substrate
    98 transmembrane aspartates
    99 variants
    100 β-amyloid precursor protein
    101 γ-secretase
    102 γ-secretase activity
    103 schema:name Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
    104 schema:pagination 513-517
    105 schema:productId Nb99a3f90f537489e986437db1673aabe
    106 Ndc226560ab1e497ca147f02d02d7e9ed
    107 Nfe921115e0c54aae8626b20604b61096
    108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004359799
    109 https://doi.org/10.1038/19077
    110 schema:sdDatePublished 2022-12-01T06:22
    111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    112 schema:sdPublisher N97ba1e8ee00941ab8c7bd5b22eb30843
    113 schema:url https://doi.org/10.1038/19077
    114 sgo:license sg:explorer/license/
    115 sgo:sdDataset articles
    116 rdf:type schema:ScholarlyArticle
    117 N03430eed234445fea60ed46a31d7329b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Peptide Fragments
    119 rdf:type schema:DefinedTerm
    120 N06638c2b19a34ca5bf491557ad4311dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Presenilin-1
    122 rdf:type schema:DefinedTerm
    123 N0c15082fecb54e4db18c218457b0963d rdf:first sg:person.01021240275.83
    124 rdf:rest N1f5d40e343e94fed89e617186db96c2a
    125 N0cc9a639685441598be599c5ccd508c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name CHO Cells
    127 rdf:type schema:DefinedTerm
    128 N0fe8598898564c749e1b8dd91c7404cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Recombinant Proteins
    130 rdf:type schema:DefinedTerm
    131 N11a1bb0eb94a494b8019b586e7de139a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Aspartic Acid
    133 rdf:type schema:DefinedTerm
    134 N11cd40ee8b7a4f0e97a3be3e8d62c78a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Transfection
    136 rdf:type schema:DefinedTerm
    137 N15ee802ee52b40a8840466f4f0fd2bc0 rdf:first sg:person.0611613126.35
    138 rdf:rest N5c4ff82ca216435caf391304e39f4a96
    139 N1f5d40e343e94fed89e617186db96c2a rdf:first sg:person.01277266475.09
    140 rdf:rest N15ee802ee52b40a8840466f4f0fd2bc0
    141 N209d423470494b238e77022dd6676a34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Microsomes
    143 rdf:type schema:DefinedTerm
    144 N2312c6ea39b844dbbdfe23b57d1bbf1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Amyloid beta-Protein Precursor
    146 rdf:type schema:DefinedTerm
    147 N2ae83eca851e4d7b89adfff987157edd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Humans
    149 rdf:type schema:DefinedTerm
    150 N3226b200aa5c4c3f835787ee3a9d3296 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Cell Line
    152 rdf:type schema:DefinedTerm
    153 N3afecbc855f140e5be4d28fd950d011c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Coenzymes
    155 rdf:type schema:DefinedTerm
    156 N46dc1305600f42c0be2717142b2edb29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Membrane Proteins
    158 rdf:type schema:DefinedTerm
    159 N5c4ff82ca216435caf391304e39f4a96 rdf:first sg:person.0606140311.52
    160 rdf:rest rdf:nil
    161 N608d96d11f1242b088d4e0db58e98673 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Animals
    163 rdf:type schema:DefinedTerm
    164 N62bd1190bfe8438b972d66fe509e61f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Protein Folding
    166 rdf:type schema:DefinedTerm
    167 N7a1e2e6228814c2d8be0325021f9d07c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Mutagenesis, Site-Directed
    169 rdf:type schema:DefinedTerm
    170 N848c0304e86d4e0eb1daf2a0fd2fae5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Amyloid beta-Peptides
    172 rdf:type schema:DefinedTerm
    173 N8846016a62164997936b90dfe6e66b38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Amyloid Precursor Protein Secretases
    175 rdf:type schema:DefinedTerm
    176 N8bb3b1761f3c4a25aade99e53235d770 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Exons
    178 rdf:type schema:DefinedTerm
    179 N8c1aa9db905f4df199744a9c2cdea308 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Electrochemistry
    181 rdf:type schema:DefinedTerm
    182 N8f22642d182a4e32b15db3cc2c5dba26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Cell Membrane
    184 rdf:type schema:DefinedTerm
    185 N97ba1e8ee00941ab8c7bd5b22eb30843 schema:name Springer Nature - SN SciGraph project
    186 rdf:type schema:Organization
    187 Nad7763ff249c4146b37aa43a41942b74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Endopeptidases
    189 rdf:type schema:DefinedTerm
    190 Nb99a3f90f537489e986437db1673aabe schema:name pubmed_id
    191 schema:value 10206644
    192 rdf:type schema:PropertyValue
    193 Nbb576ccef2254036ae3716f6be9de43f rdf:first sg:person.0735711351.49
    194 rdf:rest N0c15082fecb54e4db18c218457b0963d
    195 Nbc435153d7784364ab82058588635b60 rdf:first sg:person.0624424615.15
    196 rdf:rest Nbb576ccef2254036ae3716f6be9de43f
    197 Nc7a2e015729646c990aca2bce1977e65 schema:issueNumber 6727
    198 rdf:type schema:PublicationIssue
    199 Ndc226560ab1e497ca147f02d02d7e9ed schema:name dimensions_id
    200 schema:value pub.1004359799
    201 rdf:type schema:PropertyValue
    202 Ne12e990492484e36b471feb15c008916 schema:volumeNumber 398
    203 rdf:type schema:PublicationVolume
    204 Ne29f23f6a14f47f3a2d052e4d10809d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name COS Cells
    206 rdf:type schema:DefinedTerm
    207 Nf1870a37bbfc44079a2506e3a2d42ac5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Aspartic Acid Endopeptidases
    209 rdf:type schema:DefinedTerm
    210 Nf99bc7c51f0148dba686533d6e25166b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    211 schema:name Alzheimer Disease
    212 rdf:type schema:DefinedTerm
    213 Nfb30e7a2d44f4ae39e383e52a0eed443 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    214 schema:name Cell-Free System
    215 rdf:type schema:DefinedTerm
    216 Nfe921115e0c54aae8626b20604b61096 schema:name doi
    217 schema:value 10.1038/19077
    218 rdf:type schema:PropertyValue
    219 Nff4cf8cf8728438fbb208e857d873286 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Cricetinae
    221 rdf:type schema:DefinedTerm
    222 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    223 schema:name Medical and Health Sciences
    224 rdf:type schema:DefinedTerm
    225 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
    226 schema:name Neurosciences
    227 rdf:type schema:DefinedTerm
    228 sg:journal.1018957 schema:issn 0028-0836
    229 1476-4687
    230 schema:name Nature
    231 schema:publisher Springer Nature
    232 rdf:type schema:Periodical
    233 sg:person.01021240275.83 schema:affiliation grid-institutes:grid.62560.37
    234 schema:familyName Ostaszewski
    235 schema:givenName Beth L.
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021240275.83
    237 rdf:type schema:Person
    238 sg:person.01277266475.09 schema:affiliation grid-institutes:grid.62560.37
    239 schema:familyName Diehl
    240 schema:givenName Thekla S.
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277266475.09
    242 rdf:type schema:Person
    243 sg:person.0606140311.52 schema:affiliation grid-institutes:grid.62560.37
    244 schema:familyName Selkoe
    245 schema:givenName Dennis J.
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606140311.52
    247 rdf:type schema:Person
    248 sg:person.0611613126.35 schema:affiliation grid-institutes:grid.62560.37
    249 schema:familyName Kimberly
    250 schema:givenName W. Taylor
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611613126.35
    252 rdf:type schema:Person
    253 sg:person.0624424615.15 schema:affiliation grid-institutes:grid.267301.1
    254 schema:familyName Wolfe
    255 schema:givenName Michael S.
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624424615.15
    257 rdf:type schema:Person
    258 sg:person.0735711351.49 schema:affiliation grid-institutes:grid.62560.37
    259 schema:familyName Xia
    260 schema:givenName Weiming
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735711351.49
    262 rdf:type schema:Person
    263 sg:pub.10.1038/19083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048748829
    264 https://doi.org/10.1038/19083
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/30756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041325757
    267 https://doi.org/10.1038/30756
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/34910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053079917
    270 https://doi.org/10.1038/34910
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/359322a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026401285
    273 https://doi.org/10.1038/359322a0
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1038/387288a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005421437
    276 https://doi.org/10.1038/387288a0
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1038/nm0296-224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001947768
    279 https://doi.org/10.1038/nm0296-224
    280 rdf:type schema:CreativeWork
    281 grid-institutes:grid.267301.1 schema:alternateName Department of Pharmaceutical Sciences, University of Tennessee, 38163, Memphis, Tennessee, USA
    282 schema:name Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA
    283 Department of Pharmaceutical Sciences, University of Tennessee, 38163, Memphis, Tennessee, USA
    284 rdf:type schema:Organization
    285 grid-institutes:grid.62560.37 schema:alternateName Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA
    286 schema:name Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, 02115, Boston, Massachusetts, USA
    287 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...